a carbonic acid anhydrase inhibitor used in treatment of open-angle glaucoma and ocular hypertension, administered topically to the conjunctiva as the hydrochloride salt.
indications It is prescribed in the treatment of glaucoma. It reduces intraocular pressure by decreasing the rate of fluid production.
contraindications It should not be given to patients wearing soft contact lenses or those with allergy to dorzolamide or its components or related substances.
adverse effects The side effects most often reported include ocular burning, stinging or discomfort following use; tearing; blurred vision; or light sensitivity.